05-632. Clinical Center; Notice of Meeting  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the NIH Advisory Board for Clinical Research.

    The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(6), title 5 U.S.C., as amended for discussion of personal qualifications and performance, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: NIH Advisory Board for Clinical Research.

    Date: January 31, 2005.

    Open: 2 p.m. to 4 p.m.

    Agenda: To review the Clinical Center operating plan, ABCR workgroups and Budget update.

    Place: National Institutes of Health, Building 10, 10 Center Drive, 4-2551, CRC Medical Board Room, Bethesda, MD 20892.

    Closed: 4 p.m. to 5 p.m.

    Agenda: For discussion of personal qualifications and performance the disclosure of which constitute a clearly unwarranted invasion of personal privacy.

    Place: National Institutes of Health, Building 10, 10 Center Drive, 4-2551, CRC Medical Board Room, Bethesda, MD 20892.

    Contact Person: Maureen E. Gormley, Executive Secretary, Warren Grant Magnuson Clinical Center, National Institutes of Health, Building 10, Room 6-1610, Bethesda, MD 20892, (301) 496-2897,

    Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

    Start Signature

    Dated: January 6, 2005.

    Laverne Y, Stringfield,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 05-632 Filed 1-11-05; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
1/31/2005
Published:
01/12/2005
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
05-632
Dates:
January 31, 2005.
Pages:
2177-2177 (1 pages)
PDF File:
05-632.pdf